Cargando…

Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A(2A) receptors

Synaptic plasticity in the autoassociative network of recurrent connections among hippocampal CA3 pyramidal cells is thought to enable the storage of episodic memory. Impaired episodic memory is an early manifestation of cognitive deficits in Alzheimer's disease (AD). In the APP/PS1 mouse model...

Descripción completa

Detalles Bibliográficos
Autores principales: Viana da Silva, Silvia, Haberl, Matthias Georg, Zhang, Pei, Bethge, Philipp, Lemos, Cristina, Gonçalves, Nélio, Gorlewicz, Adam, Malezieux, Meryl, Gonçalves, Francisco Q., Grosjean, Noëlle, Blanchet, Christophe, Frick, Andreas, Nägerl, U Valentin, Cunha, Rodrigo A., Mulle, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915032/
https://www.ncbi.nlm.nih.gov/pubmed/27312972
http://dx.doi.org/10.1038/ncomms11915
_version_ 1782438632009760768
author Viana da Silva, Silvia
Haberl, Matthias Georg
Zhang, Pei
Bethge, Philipp
Lemos, Cristina
Gonçalves, Nélio
Gorlewicz, Adam
Malezieux, Meryl
Gonçalves, Francisco Q.
Grosjean, Noëlle
Blanchet, Christophe
Frick, Andreas
Nägerl, U Valentin
Cunha, Rodrigo A.
Mulle, Christophe
author_facet Viana da Silva, Silvia
Haberl, Matthias Georg
Zhang, Pei
Bethge, Philipp
Lemos, Cristina
Gonçalves, Nélio
Gorlewicz, Adam
Malezieux, Meryl
Gonçalves, Francisco Q.
Grosjean, Noëlle
Blanchet, Christophe
Frick, Andreas
Nägerl, U Valentin
Cunha, Rodrigo A.
Mulle, Christophe
author_sort Viana da Silva, Silvia
collection PubMed
description Synaptic plasticity in the autoassociative network of recurrent connections among hippocampal CA3 pyramidal cells is thought to enable the storage of episodic memory. Impaired episodic memory is an early manifestation of cognitive deficits in Alzheimer's disease (AD). In the APP/PS1 mouse model of AD amyloidosis, we show that associative long-term synaptic potentiation (LTP) is abolished in CA3 pyramidal cells at an early stage. This is caused by activation of upregulated neuronal adenosine A(2A) receptors (A(2A)R) rather than by dysregulation of NMDAR signalling or altered dendritic spine morphology. Neutralization of A(2A)R by acute pharmacological inhibition, or downregulation driven by shRNA interference in a single postsynaptic neuron restore associative CA3 LTP. Accordingly, treatment with A(2A)R antagonists reverts one-trial memory deficits. These results provide mechanistic support to encourage testing the therapeutic efficacy of A(2A)R antagonists in early AD patients.
format Online
Article
Text
id pubmed-4915032
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-49150322016-06-29 Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A(2A) receptors Viana da Silva, Silvia Haberl, Matthias Georg Zhang, Pei Bethge, Philipp Lemos, Cristina Gonçalves, Nélio Gorlewicz, Adam Malezieux, Meryl Gonçalves, Francisco Q. Grosjean, Noëlle Blanchet, Christophe Frick, Andreas Nägerl, U Valentin Cunha, Rodrigo A. Mulle, Christophe Nat Commun Article Synaptic plasticity in the autoassociative network of recurrent connections among hippocampal CA3 pyramidal cells is thought to enable the storage of episodic memory. Impaired episodic memory is an early manifestation of cognitive deficits in Alzheimer's disease (AD). In the APP/PS1 mouse model of AD amyloidosis, we show that associative long-term synaptic potentiation (LTP) is abolished in CA3 pyramidal cells at an early stage. This is caused by activation of upregulated neuronal adenosine A(2A) receptors (A(2A)R) rather than by dysregulation of NMDAR signalling or altered dendritic spine morphology. Neutralization of A(2A)R by acute pharmacological inhibition, or downregulation driven by shRNA interference in a single postsynaptic neuron restore associative CA3 LTP. Accordingly, treatment with A(2A)R antagonists reverts one-trial memory deficits. These results provide mechanistic support to encourage testing the therapeutic efficacy of A(2A)R antagonists in early AD patients. Nature Publishing Group 2016-06-17 /pmc/articles/PMC4915032/ /pubmed/27312972 http://dx.doi.org/10.1038/ncomms11915 Text en Copyright © 2016, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Viana da Silva, Silvia
Haberl, Matthias Georg
Zhang, Pei
Bethge, Philipp
Lemos, Cristina
Gonçalves, Nélio
Gorlewicz, Adam
Malezieux, Meryl
Gonçalves, Francisco Q.
Grosjean, Noëlle
Blanchet, Christophe
Frick, Andreas
Nägerl, U Valentin
Cunha, Rodrigo A.
Mulle, Christophe
Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A(2A) receptors
title Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A(2A) receptors
title_full Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A(2A) receptors
title_fullStr Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A(2A) receptors
title_full_unstemmed Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A(2A) receptors
title_short Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A(2A) receptors
title_sort early synaptic deficits in the app/ps1 mouse model of alzheimer's disease involve neuronal adenosine a(2a) receptors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915032/
https://www.ncbi.nlm.nih.gov/pubmed/27312972
http://dx.doi.org/10.1038/ncomms11915
work_keys_str_mv AT vianadasilvasilvia earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors
AT haberlmatthiasgeorg earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors
AT zhangpei earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors
AT bethgephilipp earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors
AT lemoscristina earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors
AT goncalvesnelio earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors
AT gorlewiczadam earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors
AT malezieuxmeryl earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors
AT goncalvesfranciscoq earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors
AT grosjeannoelle earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors
AT blanchetchristophe earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors
AT frickandreas earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors
AT nagerluvalentin earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors
AT cunharodrigoa earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors
AT mullechristophe earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors